Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

Oncogene volume 20, pages 2844–2853 (2001)Cite this article

Abstract

Many studies suggest that a multi-tissue tumour suppressor gene is located at human chromosome 7q31.1. We have cloned and characterized a novel gene at this locus. The TES gene lies within the minimal region of overlap of several LOH studies and appears to possess the properties of a tumour suppressor. TES is widely expressed and is predicted to encode a protein of 421 amino acids, with three C-terminal LIM domains. Mutation analysis of the coding TES exons in 21 human tumour-derived cell lines revealed the presence of a frameshift mutation in one allele in the breast cancer cell line ZR-75. Methylation of the CpG island at the 5′ end of TES appears to be a remarkably frequent finding, occurring in seven out of 10 ovarian carcinomas and in each of the 30 tumour-derived cell lines tested. Moreover, forced expression of TES in HeLa or OVCAR5 cells, resulted in a profound reduction in growth potential, as determined by the colony formation assay. We believe that TES is a tumour suppressor gene that is inactivated primarily by transcriptional silencing resulting from CpG island methylation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Achille A, Biasi MO, Zamboni G, Magalini AR, Pederzoli P, Perucho M, Scarpa A . 1996 Cancer Res. 56: 3808–3813

  • Atkin NB, Baker MC . 1993 Cancer Genet. Cytogenet. 67: 123–125

  • Baylin SB, Herman JG . 2000 Trends Genet. 16: 168–174

  • Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R . 1992 Lancet 339: 139–143

  • Costanzi-Strauss E, Strauss BE, Naviaux RK, Haas M . 1998 Exp. Cell Res. 238: 51–62

  • Divecha N, Charleston B . 1995 Gene 156: 283–286

  • Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson RL, Lee B . 1998 Nat. Gen. 19: 47–50

  • Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC . 1997 Oncogene 14: 2979–2984

  • Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG . 2000 J. Natl. Cancer Inst. 92: 564–569

  • Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ . 1999 Cancer Res. 59: 1090–1095

  • Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB . 1995 Cancer Res. 55: 4525–4530

  • Hobert O, Schilling JW, Beckerle MC, Ullrich A, Jallal B . 1996 Oncogene 12: 1577–1581

  • Hobert O, Westphal H . 2000 Trends Genet. 16: 75–83

  • Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM . 1999 Oncogene 18: 1881–1890

  • Kerr J, Leary JA, Hurst T, Shih YC, Antalis TM, Friedlander M, Crawford E, Khoo SK, Ward B, Chenevix-Trench G . 1996 Oncogene 13: 1815–1818

  • Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N, Koeffler HP . 1997 Genes Chroms Cancer 19: 1–5

  • Kozak M . 1996 Mamm. Genome 7: 563–574

  • Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Akama Y, Kitahara K, Fujii K, Tahara E . 1994 Int. J. Cancer 59: 597–600

  • Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A . 1991 Nucleic Acids Res. 19: 4293

  • Maniatis T, Fritsch EF, Sambrook J . Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY

  • Matsuya M, Sasaki H, Aoto H, Mitaka T, Nagura K, Ohba T, Ishino M, Takahashi S, Suzuki R, Sasaki T . 1998 J. Biol. Chem. 273: 1003–1014

  • Murthy KK, Clark K, Fortin Y, Shen SH, Banville D . 1999 J. Biol. Chem. 274: 20679–20687

  • Nishiya N, Sabe H, Nose K, Shibanuma M . 1998 Nucleic Acids Res. 26: 4267–4273

  • Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M . 1993 Mol. Cell. Biol. 13: 6036–6043

  • Pedersen B, Ellegaard J . 1994 Cancer Genet. Cytogenet. 78: 181–188

  • Perez-Alvarado GC, Miles C, Michelsen JW, Louis HA, Winge DR, Beckerle MC, Summers MF . 1994 Nat. Struct. Biol. 1: 388–398

  • Schmeichel KL, Beckerle MC . 1994 Cell 79: 211–219

  • Shibanuma M, Mashimo J, Kuroki T, Nose K . 1994 J. Biol. Chem. 269: 26767–26774

  • Shibanuma M, Mochizuki E, Maniwa R, Mashimo J, Nishiya N, Imai S, Takano T, Oshimura M, Nose K . 1997 Mol. Cell. Biol. 17: 1224–1235

  • Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI . 1997 Oncogene 15: 2727–2733

  • Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ . 2000 J. Natl. Cancer Inst. 92: 569–573

  • Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD . 1998 Proc. Natl. Acad. Sci. USA 95: 8698–8702

  • Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH . 1994 Cell 78: 45–57

  • Wilson R, Ainscough R, Anderson K, Baynes C, Berks M, Bonfield J, Burton J, Connell M, Copsey T, Cooper J . 1994 Nature 368: 32–38

  • Wu R, Durick K, Songyang Z, Cantley LC, Taylor SS, Gill GN . 1996 J. Biol. Chem. 271: 15934–15941

  • Wu RY, Gill GN . 1994 J. Biol. Chem. 269: 25085–25090

  • Zenklusen JC, Bieche I, Lidereau R, Conti CJ . 1994a Proc. Natl. Acad. Sci. USA 91: 12155–12158

  • Zenklusen JC, Conti CJ . 1996 Mol. Carcinog. 15: 167–175

  • Zenklusen JC, Oshimura M, Barrett JC, Conti CJ . 1994b Oncogene 9: 2817–2825

  • Zenklusen JC, Rodriguez LV, LaCava M, Wang Z, Goldstein LS, Conti CJ . 1996 Genome Res. 6: 1070–1076

  • Zenklusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ . 1995a Cancer Res. 55: 1347–1350

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ . 1994c Cancer Res. 54: 6370–6373

  • Zenklusen JC, Weitzel JN, Ball HG, Conti CJ . 1995b Oncogene 11: 359–363

Download references

Acknowledgements

We would like to thank Prof N Lemoine (ICRF, London) for the pancreatic tumour cell lines and Prof R Brown (Medical Oncology, University of Glasgow) for the ovarian tumours and cell lines used in this study. This work has been supported by a programme grant from The Cancer Research Campaign (CRC) of the United Kingdom. Accession number GenBank accession no. AJ250865

Author information

Author notes

  1. E S Tobias and A F L Hurlstone: ES Tobias and AFL Hurlstone contributed equally

Authors and Affiliations

  1. Beatson Institute for Cancer Research, CRC Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK

    E S Tobias, E MacKenzie, R McFarlane & D M Black

  2. Department of Immunology, University Hospital Utrecht, Heidelberglaan 100, Utrecht, 3584CX, The Netherlands

    A F L Hurlstone

Authors
  1. E S Tobias
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A F L Hurlstone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E MacKenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R McFarlane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D M Black
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tobias, E., Hurlstone, A., MacKenzie, E. et al. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 20, 2844–2853 (2001). https://doi.org/10.1038/sj.onc.1204433

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204433

Keywords

This article is cited by

Search

Advanced search

Quick links